On the back of headwinds in its EU business and discontinuation of liquids business in the US, Torrent Pharmaceuticals Ltd. (TPL) posted a net loss of Rs 118 crore for the fourth quarter ended March 31, 2022. On a year-on-year (YoY) basis, the company had registered a profit after tax (PAT) of Rs 324 crore in the corresponding quarter of last year.
The company's revenue, however, grew by 10 per cent to Rs 2,131 crore in Q4 of FY22 aided by strong growth momentum in branded generic markets. Torrent Pharma's revenue for Q4 FY21 was Rs 1937 crore. On an